← Back to Search

18F-LY3950321 Whole Body Dosimetry for Nuclear Radiation Emergency

Phase < 1
Waitlist Available
Research Sponsored by Avid Radiopharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male subjects must not donate sperm for the study duration and for 90 days after study completion.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up injection to 4 hours postdose
Awards & highlights

Study Summary

This trial is testing the safety and radiation exposure of a new imaging tool that targets a protein involved in the body's immune response.

Eligible Conditions
  • Nuclear Radiation Emergency
  • Adverse Reaction

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Male participants are precluded from donating sperm during and for 90 days following the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~injection to 4 hours postdose
This trial's timeline: 3 weeks for screening, Varies for treatment, and injection to 4 hours postdose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
18F-LY3950321 Whole Body Effective Dose

Trial Design

1Treatment groups
Experimental Treatment
Group I: 18F-LY3950321 Whole Body DosimetryExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PET Scan
2006
Completed Phase 3
~590
18F-LY3950321
2023
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

Avid RadiopharmaceuticalsLead Sponsor
65 Previous Clinical Trials
9,708 Total Patients Enrolled
Avid Medical DirectorStudy DirectorAvid Radiopharmaceuticals, Inc.
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any fresh applicants being welcomed for this research?

"Clinicaltrials.gov confirms that this investigation is actively searching for participants since it was initially advertised on February 28th, 2023 and edited as recently as March 20th, 2023."

Answered by AI

What is the approximate number of participants in this research initiative?

"Correct. According to the information presented on clinicaltrials.gov, this medical study which began recruiting participants on February 28th 2023 is still actively searching for test subjects. A total of 6 people will be needed at one location in order to complete recruitment goals."

Answered by AI
~3 spots leftby Mar 2025